| SCHOLAR ROCK HLDG DL-,001 |
| USA |
| Gesundheit |
| US80706P1030 / A2JMQW |
| 2QK (Frankfurt) / SRRK (NASDAQ) |
| FRA:2QK, ETR:2QK, 2QK:GR, NASDAQ:SRRK |
| - |
| https://scholarrock.com/ |
|
Scholar Rock Holding Corporation Common Stock represents an equity interest in Scholar Rock Holding Corporation, a biopharmaceutical company focused on discovering, developing, and delivering medicines for serious diseases, with an emphasis on rare n..
>Volltext.. |
| 5038.58 Mio. EUR |
| 4784.2 Mio. EUR |
| - |
| -363.44 Mio. EUR |
| -366.77 Mio. EUR |
| -3.1 EUR |
| 182.97 Mio. EUR |
| 392.35 Mio. EUR |
| -266.45 Mio. EUR |
| 6.81 |
| - |
| -33.5% |
| - |
| - |
| - |
| SCHOLAR ROCK |
| 10.11.26 |